Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials
Highlights • Brivaracetam was effect for refractory partial seizure in the present study. • Brivaracetam was well tolerated in the present study. • Long-term efficacy and safety of brivaracetam should be further investigated.
Gespeichert in:
| Veröffentlicht in: | Epilepsy research 2015-08, Vol.114, p.59-65 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 65 |
|---|---|
| container_issue | |
| container_start_page | 59 |
| container_title | Epilepsy research |
| container_volume | 114 |
| creator | Ma, Junpeng Huang, Siqing You, Chao |
| description | Highlights • Brivaracetam was effect for refractory partial seizure in the present study. • Brivaracetam was well tolerated in the present study. • Long-term efficacy and safety of brivaracetam should be further investigated. |
| doi_str_mv | 10.1016/j.eplepsyres.2015.04.017 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1690211462</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S092012111500090X</els_id><sourcerecordid>1690211462</sourcerecordid><originalsourceid>FETCH-LOGICAL-c429t-386dd9e73beee35e5bbabd7fbda2fd9f6e7f5b29b7b908b8382fc156cccaa60b3</originalsourceid><addsrcrecordid>eNqNkk2LFDEQhoMo7uzqX5AcvXRvkv72IIyLX7DgQQVvIR_VmDHdaZP0SO_B324Nsyp4MpeC1FtvpZ4UIZSzkjPeXh9KWDwsaYuQSsF4U7K6ZLx7QHa870TR9nX9kOzYIFjBBecX5DKlA2OsY3X9mFyIlvV42h35ubeHdTbZHYHq6I4qKgNZTXQMkS4qO5hzoj9c_kojjJjMIW6YiNkpTxO4uxXf8ILu6YRlhZqV35JLNIw0qtmGyd2BpYtHVx0KE-Ycg_d4lSMapCfk0YgBnt7HK_L5zetPN--K2w9v39_sbwtTiyEXVd9aO0BXaQCoGmi0Vtp2o7ZKjHYYW-jGRotBd3pgve6rXoyGN60xRqmW6eqKPD_7LjF8XyFlOblkwHs1Q1iT5O3AkFPdCpT2Z6mJISUcWi7RTSpukjN5oi8P8i99eaIvWS2RPpY-u--y6gnsn8LfuFHw6iwAnPXoIMpkkLAB6yKYLG1w_9Pl5T8mxrvZGeW_wQbpENaIv4AzySQkkx9PW3BaAt7gAgzsS_ULNi21uA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1690211462</pqid></control><display><type>article</type><title>Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Ma, Junpeng ; Huang, Siqing ; You, Chao</creator><creatorcontrib>Ma, Junpeng ; Huang, Siqing ; You, Chao</creatorcontrib><description>Highlights • Brivaracetam was effect for refractory partial seizure in the present study. • Brivaracetam was well tolerated in the present study. • Long-term efficacy and safety of brivaracetam should be further investigated.</description><identifier>ISSN: 0920-1211</identifier><identifier>EISSN: 1872-6844</identifier><identifier>DOI: 10.1016/j.eplepsyres.2015.04.017</identifier><identifier>PMID: 26088886</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adult ; Anticonvulsants - adverse effects ; Anticonvulsants - therapeutic use ; Antiepileptic drug ; Brivaracetam ; Drug Resistant Epilepsy - drug therapy ; Drug Therapy, Combination ; Epilepsies, Partial - drug therapy ; Epilepsy ; Female ; Humans ; Male ; Middle Aged ; Neurology ; Pyrrolidinones - adverse effects ; Pyrrolidinones - therapeutic use ; Randomized Controlled Trials as Topic ; Seizures</subject><ispartof>Epilepsy research, 2015-08, Vol.114, p.59-65</ispartof><rights>Elsevier B.V.</rights><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c429t-386dd9e73beee35e5bbabd7fbda2fd9f6e7f5b29b7b908b8382fc156cccaa60b3</citedby><cites>FETCH-LOGICAL-c429t-386dd9e73beee35e5bbabd7fbda2fd9f6e7f5b29b7b908b8382fc156cccaa60b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S092012111500090X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26088886$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Junpeng</creatorcontrib><creatorcontrib>Huang, Siqing</creatorcontrib><creatorcontrib>You, Chao</creatorcontrib><title>Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials</title><title>Epilepsy research</title><addtitle>Epilepsy Res</addtitle><description>Highlights • Brivaracetam was effect for refractory partial seizure in the present study. • Brivaracetam was well tolerated in the present study. • Long-term efficacy and safety of brivaracetam should be further investigated.</description><subject>Adult</subject><subject>Anticonvulsants - adverse effects</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Antiepileptic drug</subject><subject>Brivaracetam</subject><subject>Drug Resistant Epilepsy - drug therapy</subject><subject>Drug Therapy, Combination</subject><subject>Epilepsies, Partial - drug therapy</subject><subject>Epilepsy</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Pyrrolidinones - adverse effects</subject><subject>Pyrrolidinones - therapeutic use</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Seizures</subject><issn>0920-1211</issn><issn>1872-6844</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk2LFDEQhoMo7uzqX5AcvXRvkv72IIyLX7DgQQVvIR_VmDHdaZP0SO_B324Nsyp4MpeC1FtvpZ4UIZSzkjPeXh9KWDwsaYuQSsF4U7K6ZLx7QHa870TR9nX9kOzYIFjBBecX5DKlA2OsY3X9mFyIlvV42h35ubeHdTbZHYHq6I4qKgNZTXQMkS4qO5hzoj9c_kojjJjMIW6YiNkpTxO4uxXf8ILu6YRlhZqV35JLNIw0qtmGyd2BpYtHVx0KE-Ycg_d4lSMapCfk0YgBnt7HK_L5zetPN--K2w9v39_sbwtTiyEXVd9aO0BXaQCoGmi0Vtp2o7ZKjHYYW-jGRotBd3pgve6rXoyGN60xRqmW6eqKPD_7LjF8XyFlOblkwHs1Q1iT5O3AkFPdCpT2Z6mJISUcWi7RTSpukjN5oi8P8i99eaIvWS2RPpY-u--y6gnsn8LfuFHw6iwAnPXoIMpkkLAB6yKYLG1w_9Pl5T8mxrvZGeW_wQbpENaIv4AzySQkkx9PW3BaAt7gAgzsS_ULNi21uA</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Ma, Junpeng</creator><creator>Huang, Siqing</creator><creator>You, Chao</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150801</creationdate><title>Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials</title><author>Ma, Junpeng ; Huang, Siqing ; You, Chao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c429t-386dd9e73beee35e5bbabd7fbda2fd9f6e7f5b29b7b908b8382fc156cccaa60b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Anticonvulsants - adverse effects</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Antiepileptic drug</topic><topic>Brivaracetam</topic><topic>Drug Resistant Epilepsy - drug therapy</topic><topic>Drug Therapy, Combination</topic><topic>Epilepsies, Partial - drug therapy</topic><topic>Epilepsy</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Pyrrolidinones - adverse effects</topic><topic>Pyrrolidinones - therapeutic use</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Seizures</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ma, Junpeng</creatorcontrib><creatorcontrib>Huang, Siqing</creatorcontrib><creatorcontrib>You, Chao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Epilepsy research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Junpeng</au><au>Huang, Siqing</au><au>You, Chao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials</atitle><jtitle>Epilepsy research</jtitle><addtitle>Epilepsy Res</addtitle><date>2015-08-01</date><risdate>2015</risdate><volume>114</volume><spage>59</spage><epage>65</epage><pages>59-65</pages><issn>0920-1211</issn><eissn>1872-6844</eissn><abstract>Highlights • Brivaracetam was effect for refractory partial seizure in the present study. • Brivaracetam was well tolerated in the present study. • Long-term efficacy and safety of brivaracetam should be further investigated.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26088886</pmid><doi>10.1016/j.eplepsyres.2015.04.017</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0920-1211 |
| ispartof | Epilepsy research, 2015-08, Vol.114, p.59-65 |
| issn | 0920-1211 1872-6844 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1690211462 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adult Anticonvulsants - adverse effects Anticonvulsants - therapeutic use Antiepileptic drug Brivaracetam Drug Resistant Epilepsy - drug therapy Drug Therapy, Combination Epilepsies, Partial - drug therapy Epilepsy Female Humans Male Middle Aged Neurology Pyrrolidinones - adverse effects Pyrrolidinones - therapeutic use Randomized Controlled Trials as Topic Seizures |
| title | Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T12%3A07%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adjunctive%20brivaracetam%20for%20patients%20with%20refractory%20partial%20seizures:%20A%20meta-analysis%20of%20randomized%20placebo-controlled%20trials&rft.jtitle=Epilepsy%20research&rft.au=Ma,%20Junpeng&rft.date=2015-08-01&rft.volume=114&rft.spage=59&rft.epage=65&rft.pages=59-65&rft.issn=0920-1211&rft.eissn=1872-6844&rft_id=info:doi/10.1016/j.eplepsyres.2015.04.017&rft_dat=%3Cproquest_cross%3E1690211462%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1690211462&rft_id=info:pmid/26088886&rft_els_id=S092012111500090X&rfr_iscdi=true |